Mary Brainerd - STRYKER Independent Director
| SYK Stock | EUR 364.80 7.40 1.99% |
Director
Ms. Mary K. Brainerd is Independent Director of the company. She is a former President and Chief Executive Officer of HealthPartners, the largest, consumergoverned, nonprofit health care organization in the United States, which she led from 2002 to May 2017. Prior to joining HealthPartners in 1992, she held various executive roles with Blue Cross and Blue Shield of Minnesota from 1984 to 1992. She also serves as a director of Bremer Bank and Securian Financial, a financial services company headquartered in Minneapolis. Ms. Brainerds extensive experience surrounding both health care delivery and insurance enable her to provide unique and invaluable insight to our Board discussions, particularly in light of the evolving landscape in the health care delivery and payer markets. since 2017.
| Age | 65 |
| Tenure | 7 years |
STRYKER Leadership Team
Elected by the shareholders, the STRYKER's board of directors comprises two types of representatives: STRYKER inside directors who are chosen from within the company, and outside directors, selected externally and held independent of STRYKER. The board's role is to monitor STRYKER's management team and ensure that shareholders' interests are well served. STRYKER's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, STRYKER's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Silvernail, Independent Director | ||
| Sherilyn McCoy, Independent Director | ||
| Ronda Stryker, Independent Director | ||
| Rajeev Suri, Independent Director | ||
| Preston Wells, Vice President - Investor Relations | ||
| Glenn Boehnlein, Chief Financial Officer, Vice President | ||
| Viju Menon, Group President - Global Quality and Business Operations | ||
| William Berry, Principal Accounting Officer, Vice President Corporate Controller | ||
| Allan Golston, Lead Independent Director | ||
| Mary Brainerd, Independent Director | ||
| Srikant Datar, Independent Director | ||
| Kevin Lobo, Chairman of the Board, Chief Executive Officer | ||
| Giovanni Caforio, Director | ||
| Roch Doliveux, Independent Director | ||
| Yin Becker, Vice President - Communications, Public Affairs and Corporate Marketing | ||
| M Fink, Chief Human Resource Officer, Vice President | ||
| Timothy Scannell, Group President - MedSurg and Neurotechnology | ||
| Robert Fletcher, Vice President Chief Legal Officer |
STRYKER Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is STRYKER a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 101.82 B | |||
| Price To Book | 5.78 X | |||
| Price To Sales | 5.36 X | |||
| Revenue | 18.45 B | |||
| EBITDA | 4.04 B | |||
| Net Income | 2.36 B | |||
| Total Debt | 11.86 B | |||
| Cash Flow From Operations | 2.62 B | |||
| Price To Earnings To Growth | 2.83 X | |||
| Number Of Employees | 35 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in STRYKER Stock
When determining whether STRYKER is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if STRYKER Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STRYKER. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade STRYKER Stock refer to our How to Trade STRYKER Stock guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.